AAAAAA

   
Results: 1-8 |
Results: 8
ORAL ONDANSETRON-8-MG TWICE-DAILY IS AS EFFECTIVE AS 8-MG 3 TIMES DAILY IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MODERATELYEMETOGENIC CANCER-CHEMOTHERAPY
Authors: BECK TM YORK M CHANG A NAVARI R HARVEY WH MESHAD M GRIFFIN D WENTZ A
Citation: Tm. Beck et al., ORAL ONDANSETRON-8-MG TWICE-DAILY IS AS EFFECTIVE AS 8-MG 3 TIMES DAILY IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MODERATELYEMETOGENIC CANCER-CHEMOTHERAPY, Cancer investigation, 15(4), 1997, pp. 297-303
SUCCESSFUL IN-VITRO PURGING OF LEUKEMIC BLASTS FROM MARROW BY CORTIVAZOL, A PYRAZOLOSTEROID - A PRECLINICAL STUDY FOR AUTOLOGOUS TRANSPLANTATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA AND NON-HODGKINS-LYMPHOMA
Authors: JUNEJA HS HARVEY WH BRASHER WK THOMPSON EB
Citation: Hs. Juneja et al., SUCCESSFUL IN-VITRO PURGING OF LEUKEMIC BLASTS FROM MARROW BY CORTIVAZOL, A PYRAZOLOSTEROID - A PRECLINICAL STUDY FOR AUTOLOGOUS TRANSPLANTATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA AND NON-HODGKINS-LYMPHOMA, Leukemia, 9(10), 1995, pp. 1771-1778
INTERFERON-ALPHA-2B DOWN-REGULATION OF ONCOGENES H-RAS, C-RAF-2, C-KIT, C-MYC, C-MYB, AND C-FOS IN ESKOL, A HAIRY-CELL LEUKEMIC LINE RESULTS IN TEMPORAL PERTURBATION OF SIGNAL-TRANSDUCTION CASCADE
Authors: HARVEY WH HARB OS KOSAK ST SHEAFFER JC LOWE LR HEEREMA NA
Citation: Wh. Harvey et al., INTERFERON-ALPHA-2B DOWN-REGULATION OF ONCOGENES H-RAS, C-RAF-2, C-KIT, C-MYC, C-MYB, AND C-FOS IN ESKOL, A HAIRY-CELL LEUKEMIC LINE RESULTS IN TEMPORAL PERTURBATION OF SIGNAL-TRANSDUCTION CASCADE, Journal of cellular biochemistry, 1995, pp. 35-35
DIDEMNIN-B IN METASTATIC MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THESOUTHWEST-ONCOLOGY-GROUP
Authors: SONDAK VK KOPECKY KJ LIU PY FLETCHER WS HARVEY WH LAUFMAN LR
Citation: Vk. Sondak et al., DIDEMNIN-B IN METASTATIC MALIGNANT-MELANOMA - A PHASE-II TRIAL OF THESOUTHWEST-ONCOLOGY-GROUP, Anti-cancer drugs, 5(2), 1994, pp. 147-150
A RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS ONDANSETRON ALONE AND IN COMBINATION WITH INTRAVENOUS DEXAMETHASONE IN THE PREVENTION OF HIGH-DOSE CISPLATIN-INDUCED EMESIS
Authors: HESKETH PJ HARVEY WH HARKER WG BECK TM RYAN T BRICKER LJ KISH JA MURPHY WK HAINSWORTH JD HALEY B PLAGGE P FLACK NE
Citation: Pj. Hesketh et al., A RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS ONDANSETRON ALONE AND IN COMBINATION WITH INTRAVENOUS DEXAMETHASONE IN THE PREVENTION OF HIGH-DOSE CISPLATIN-INDUCED EMESIS, Journal of clinical oncology, 12(3), 1994, pp. 596-600
HEPATOMA MERBARONE - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: POPLIN EA TANGEN CM HARVEY WH MACDONALD JS
Citation: Ea. Poplin et al., HEPATOMA MERBARONE - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Investigational new drugs, 12(4), 1994, pp. 337-340
INTERFERON-ALPHA-2B DOWN-REGULATION OF ONCOGENES H-RAS, C-RAF-2, C-KIT, C-MYC, C-MYB AND C-FOS IN ESKOL, A HAIRY-CELL LEUKEMIC LINE, RESULTS IN TEMPORAL PERTURBATION OF SIGNAL-TRANSDUCTION CASCADE
Authors: HARVEY WH HARB OS KOSAK ST SHEAFFER JC LOWE LR HEEREMA NA
Citation: Wh. Harvey et al., INTERFERON-ALPHA-2B DOWN-REGULATION OF ONCOGENES H-RAS, C-RAF-2, C-KIT, C-MYC, C-MYB AND C-FOS IN ESKOL, A HAIRY-CELL LEUKEMIC LINE, RESULTS IN TEMPORAL PERTURBATION OF SIGNAL-TRANSDUCTION CASCADE, Leukemia research, 18(8), 1994, pp. 577-585
PHASE-II STUDY OF TRIMETREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH HEPATOCELLULAR-CARCINOMA - SOUTHWEST-ONCOLOGY-GROUP STUDY 8712
Authors: HARVEY WH FLEMING TR GOODMAN PJ HARVEY JH RIVKIN SE MACDONALD JS
Citation: Wh. Harvey et al., PHASE-II STUDY OF TRIMETREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH HEPATOCELLULAR-CARCINOMA - SOUTHWEST-ONCOLOGY-GROUP STUDY 8712, Investigational new drugs, 11(1), 1993, pp. 45-46
Risultati: 1-8 |